ARCHIVES

Hearing Scheduled To Investigate ImClone’s C225 Development, Stock Trading

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

President Obama Signs Recalcitrant Cancer Bill

January 4, 2013

Agency Expands Gleevec Label To Include Rare GIST Subset

February 24, 2012

14 Institutions Awarded $100 Million for AIDS Treatment Evaluation Units

July 4, 1986

ACS Finds 1 In 4 US Deaths From Cancer; Weiss Named NCI Centers Branch Chief.

January 18, 2002

House Bill Provides 5.7% Increase To NIH, But Passage Threatened By Amendments

August 4, 1995

HEW Finally Moves On Distribution Of Chemicals

September 7, 1979